AXIM Biotechnologies, Inc. AXIM OTC

AXIM Biotechnologies, Inc. (AXIM) reported total assets of $3.22M and total liabilities of $13.65M for quarter ending 2025-06-30, resulting in total equity of $-10.43M.

The company held $2.8K in cash and short-term investments. Total debt stood at $7.55M, with net debt of $7.54M. The Debt-to-Equity (D/E) ratio was -0.72 (conservative).

Current ratio is 0, which may signal tight short-term liquidity. Interest coverage is -3.4x (weak).

Criteria supported by this page:

• HEALTH (0/100, Fail) — the balance sheet shows elevated risk in debt or liquidity metrics
• MOAT (0/100) — Total assets $3.22M and equity $-10.43M support the company's competitive scale

Overall SharesGrow Score: 21/100 with 1/7 criteria passed.